Market Price

172.00 

2.96 1.8%

as of Sep 28 '20

52 Week Range:

108.85 209.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20
Equity (BVPS) 8.51
11.41
11.33
12.45
12.05
10.94
11.90
13.05
14.49
14.07
15.57
growth rate 34.1% -0.7% 9.9% -3.2% -9.2% 8.8% 9.7% 11.0% -2.9% 10.7%
Earnings BIT 260.59
303.71
331.95
385.12
411.41
409.24
435.87
456.73
560.26
635.99
growth rate 16.6% 9.3% 16.0% 6.8% -0.5% 6.5% 4.8% 22.7% 13.5%
Avg.PE 24.81
21.41
18.28
21.51
21.19
22.22
28.05
32.93
49.24
36.48
47.53
growth rate -13.7% -14.6% 17.7% -1.5% 4.9% 26.2% 17.4% 49.5% -25.9% 30.3%
ROA 12.13
12.29
12.12
14.13
15.10
15.53
12.95
10.18
9.66
11.28
14.30
growth rate 1.3% -1.4% 16.6% 6.9% 2.9% -16.6% -21.4% -5.1% 16.8% 26.8%
ROE 15.82
15.04
15.27
19.09
20.50
21.10
21.47
18.73
15.70
19.59
27.21
growth rate -4.9% 1.5% 25.0% 7.4% 2.9% 1.8% -12.8% -16.2% 24.8% 38.9%
ROIC 14.67
13.59
12.60
14.92
16.38
17.04
13.76
12.53
11.98
15.17
18.35
growth rate -7.4% -7.3% 18.4% 9.8% 4.0% -19.3% -8.9% -4.4% 26.6% 21.0%
Cur. Ratio 3.15
6.19
5.38
2.52
5.77
5.40
2.22
4.57
2.08
2.06
2.53
growth rate 96.5% -13.1% -53.2% 129.0% -6.4% -58.9% 105.9% -54.5% -1.0% 22.8%
Quick Ratio 2.31
4.88
4.33
2.10
4.75
4.04
1.74
3.53
1.32
1.22
1.57
growth rate 111.3% -11.3% -51.5% 126.2% -15.0% -56.9% 102.9% -62.6% -7.6% 28.7%
Leverage 1.26
1.20
1.33
1.37
1.34
1.38
1.92
1.77
1.49
1.98
1.84
growth rate -4.8% 10.8% 3.0% -2.2% 3.0% 39.1% -7.8% -15.8% 32.9% -7.1%
Balance Sheet Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20
Acct.Receivable 226.90
274.40
305.03
365.81
359.59
362.57
382.09
450.53
497.02
538.32
growth rate 20.9% 11.2% 19.9% -1.7% 0.8% 5.4% 17.9% 10.3% 8.3%
Acct.Payable 211.24
229.08
85.41
81.11
92.57
92.76
92.72
115.73
growth rate 8.5% -62.7% -5.0% 14.1% 0.2% 0.0% 24.8%
Cur.Assets 985.30
1,292.50
1,361.15
1,448.85
1,556.21
1,407.84
1,419.72
1,644.00
1,065.72
1,145.37
growth rate 31.2% 5.3% 6.4% 7.4% -9.5% 0.8% 15.8% -35.2% 7.5%
Total Assets 1,626.40
2,068.90
2,137.87
2,210.72
2,360.96
2,181.77
3,256.71
3,468.49
3,063.92
4,107.68
growth rate 27.2% 3.3% 3.4% 6.8% -7.6% 49.3% 6.5% -11.7% 34.1%
Cash 488.80
735.30
809.54
876.05
905.73
717.25
731.43
821.94
188.70
147.13
growth rate 50.4% 10.1% 8.2% 3.4% -20.8% 2.0% 12.4% -77.0% -22.0%
Inventory 185.60
200.80
174.35
145.85
165.42
246.86
224.46
268.32
268.70
349.64
growth rate 8.2% -13.2% -16.4% 13.4% 49.2% -9.1% 19.5% 0.1% 30.1%
Cur.Liabilities 312.70
208.80
252.85
574.05
269.56
266.46
637.99
360.13
511.25
555.99
growth rate -33.2% 21.1% 127.0% -53.0% -1.2% 139.4% -43.6% 42.0% 8.8%
Liabilities 338.90
338.20
530.24
600.21
602.71
594.47
1,561.87
1,508.22
1,004.94
2,035.49
growth rate -0.2% 56.8% 13.2% 0.4% -1.4% 162.7% -3.4% -33.4% 102.6%
LT Debt 0.00
100.00
250.78
0.77
300.77
300.59
873.33
1,078.61
269.99
1,258.86
growth rate 150.8% -99.7% 39,011.8% -0.1% 190.5% 23.5% -75.0% 366.3%
Equity 1,287.50
1,730.70
1,607.63
1,610.52
1,758.25
1,587.31
1,694.83
1,960.27
2,058.98
2,072.19
growth rate 34.4% -7.1% 0.2% 9.2% -9.7% 6.8% 15.7% 5.0% 0.6%
Common Shares 155.00
157.00
149.00
146.00
144.00
143.00
142.00
142.00
144.00
144.00
146.00
growth rate 1.3% -5.1% -2.0% -1.4% -0.7% -0.7% 0.0% 1.4% 0.0% 1.4%
Cash Flow Statement Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20
Capital Expenditures 56.90
66.60
47.14
63.58
72.72
62.50
58.53
62.22
62.58
68.71
growth rate 17.1% -29.2% 34.9% 14.4% -14.1% -6.4% 6.3% 0.6% 9.8%
Cash Dividends 0.00
0.00
0.00
97.20
141.52
157.26
168.13
186.35
199.50
211.71
growth rate 45.6% 11.1% 6.9% 10.8% 7.1% 6.1%
Cash From OA 188.20
283.20
383.16
402.82
391.27
383.18
547.93
414.05
505.03
459.05
growth rate 50.5% 35.3% 5.1% -2.9% -2.1% 43.0% -24.4% 22.0% -9.1%
FCF per Share 0.82
1.32
1.92
2.11
2.21
2.24
3.00
2.45
3.08
2.59
3.47
growth rate 61.0% 45.5% 9.9% 4.7% 1.4% 33.9% -18.3% 25.7% -15.9% 34.0%
Sale Purchase of Stock -330.25
-117.02
33.35
38.81
27.69
30.16
23.33
growth rate 0.0% 100.0% 16.4% -28.6% 8.9% -22.6%
FCF 127.00
208.00
322.00
331.00
310.00
311.00
480.00
343.00
434.00
382.00
696.00
growth rate 63.8% 54.8% 2.8% -6.3% 0.3% 54.3% -28.5% 26.5% -12.0% 82.2%
Income Statement Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20
Sales 1,092.40
1,243.10
1,368.52
1,514.46
1,554.97
1,678.91
1,838.71
2,066.74
2,340.20
2,606.57
growth rate 13.8% 10.1% 10.7% 2.7% 8.0% 9.5% 12.4% 13.2% 11.4%
Op.Income 240.40
266.90
254.85
307.13
411.41
409.24
435.87
456.73
560.26
635.99
growth rate 11.0% -4.5% 20.5% 34.0% -0.5% 6.5% 4.8% 22.7% 13.5%
IBT 260.60
303.70
331.95
385.12
431.08
435.92
439.57
418.74
521.31
518.85
growth rate 16.5% 9.3% 16.0% 11.9% 1.1% 0.8% -4.7% 24.5% -0.5%
Net Income 190.10
227.00
254.85
307.13
345.27
352.89
352.41
342.28
315.59
404.59
growth rate 19.4% 12.3% 20.5% 12.4% 2.2% -0.1% -2.9% -7.8% 28.2%
EPS 1.23
1.44
1.71
2.10
2.39
2.47
2.49
2.40
2.19
2.80
4.27
growth rate 17.1% 18.8% 22.8% 13.8% 3.4% 0.8% -3.6% -8.8% 27.9% 52.5%
Gross Profit 655.50
741.30
820.74
940.66
989.79
1,011.40
1,066.50
1,201.75
1,362.16
1,536.59
growth rate 13.1% 10.7% 14.6% 5.2% 2.2% 5.5% 12.7% 13.4% 12.8%
R&D 75.20
92.00
109.73
144.89
118.23
114.87
118.65
144.47
155.15
180.65
growth rate 22.3% 19.3% 32.0% -18.4% -2.8% 3.3% 21.8% 7.4% 16.4%

Quarterly Statements

Item Name Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Earnings BIT 156.98
171.68
171.10
197.21
217.50
growth rate 9.4% -0.3% 15.3% 10.3%
Balance Sheet Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Acct.Receivable 521.85
538.32
502.41
535.83
563.40
growth rate 3.2% -6.7% 6.7% 5.2%
Acct.Payable 124.47
115.73
109.74
114.32
116.15
growth rate -7.0% -5.2% 4.2% 1.6%
Cur.Assets 1,102.70
1,145.37
1,161.10
1,300.49
1,469.76
growth rate 3.9% 1.4% 12.0% 13.0%
Total Assets 4,098.53
4,107.68
4,154.56
4,353.94
4,510.54
growth rate 0.2% 1.1% 4.8% 3.6%
Cash 146.51
147.13
172.15
204.10
352.86
growth rate 0.4% 17.0% 18.6% 72.9%
Inventory 319.93
349.64
357.03
377.78
358.77
growth rate 9.3% 2.1% 5.8% -5.0%
Cur.Liabilities 462.97
555.99
550.46
500.05
551.52
growth rate 20.1% -1.0% -9.2% 10.3%
Liabilities 2,077.20
2,035.49
2,037.31
2,095.83
2,254.11
growth rate -2.0% 0.1% 2.9% 7.6%
LT Debt 1,323.35
1,258.86
1,208.21
1,287.51
1,364.85
growth rate -4.9% -4.0% 6.6% 6.0%
Equity 2,021.33
2,072.19
2,117.25
2,258.11
2,256.43
growth rate 2.5% 2.2% 6.7% -0.1%
Common Shares 0.57
0.58
0.58
0.58
0.58
growth rate 0.4% 0.0% 0.5% 0.2%
Cash Flow Statement Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Capital Expenditures 15.08
22.20
22.67
25.10
29.59
growth rate 47.2% 2.1% 10.7% 17.9%
Cash Dividends 53.03
53.12
56.05
56.15
56.41
growth rate 0.2% 5.5% 0.2% 0.5%
Cash From OA 139.65
141.82
162.36
69.93
239.70
growth rate 1.6% 14.5% -56.9% 242.8%
Sale Purchase of Stock
growth rate
FCF 124.56
119.62
139.69
44.83
210.11
growth rate -4.0% 16.8% -67.9% 368.7%
Income Statement Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Sales 662.23
704.96
681.06
736.16
769.46
growth rate 6.5% -3.4% 8.1% 4.5%
Op.Income 156.98
171.68
171.10
197.21
217.50
growth rate 9.4% -0.3% 15.3% 10.3%
IBT 137.93
95.77
150.59
178.75
191.66
growth rate -30.6% 57.3% 18.7% 7.2%
Net Income 105.42
68.80
120.15
160.55
163.14
growth rate -34.7% 74.6% 33.6% 1.6%
EPS
growth rate
Gross Profit 391.91
417.85
405.06
439.18
461.80
growth rate 6.6% -3.1% 8.4% 5.2%
R&D 47.61
51.14
48.03
49.94
51.45
growth rate 7.4% -6.1% 4.0% 3.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (75.09)

YOY Growth Grade:

C (54.11)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 40.49 40.28 32.68
EPS / Growth 10.4% 4.27 21.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 4.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 4.3% 7.3% 7.3%
Future PE 8.54 29.28 29.28
Future EPS 6.49 8.67 8.67
Value Price
MOS %
13.69
-92.0%
62.76
-63.5%
62.76
-63.5%
MOS Price 6.85 31.38 31.38
IRT 23.30 18.67 18.67

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.